DrugPatentWatch Database Preview
J - Profile
US Patents for j
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms Inc | ERWINAZE | asparaginase erwinia chrysanthemi | INJECTABLE; INJECTION | 125359 | 001 | 2011-11-18 | 9,920,311 | Jazz Pharmaceuticals II SAS (Lyons, FR) | 2030-03-30 | RX | Orphan | search |
| Jazz Pharms Inc | ERWINAZE | asparaginase erwinia chrysanthemi | INJECTABLE; INJECTION | 125359 | 001 | 2011-11-18 | 10,287,294 | BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS (GR) | 2035-07-08 | RX | Orphan | search |
| Janssen Biotech | TREMFYA | guselkumab | INJECTABLE;INJECTION | 761061 | 001 | 2019-01-29 | 10,273,252 | UBE INDUSTRIES, LTD. (Yamaguchi, JP) | 2036-04-28 | RX | search | |
| Janssen Biotech | STELARA | ustekinumab | INJECTABLE;INJECTION | 761044 | 001 | 2019-11-07 | 9,907,788 | Arcutis Inc. (Menlo Park, CA) | 2037-06-07 | RX | search | |
| Janssen Biotech | STELARA | ustekinumab | INJECTABLE;INJECTION | 761044 | 001 | 2019-11-07 | 9,895,359 | ARCUTIS, INC. (Menlo Park, CA) | 2039-02-26 | RX | search | |
| Janssen Biotech | STELARA | ustekinumab | INJECTABLE;INJECTION | 761044 | 001 | 2019-11-07 | 9,872,854 | Celgene Corporation (Summit, NJ) | 2033-03-14 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
